Six Countries in Terumo's Asia Pacific Operations Achieve Best Workplaces™ Certification from Great Place To Work®

Singapore, (ANTARA/PRNewswire) - Six countries within Terumo’s Asia Pacific operational regions have successfully achieved the Best Workplaces™ certification from Great Place To Work®.

This achievement further reinforces Terumo’s commitment to creating a world-class working environment that supports employee growth and development. The recognition was awarded to Terumo’s teams in the Philippines, Singapore, Thailand, Malaysia, Vietnam, and Indonesia, which have successfully built a positive and excellent work culture within the healthcare and biopharmaceutical industries in Southeast Asia.

“Terumo believes that a good work experience begins with a corporate purpose that is meaningful to every employee. Therefore, we strive to create a working environment that is relevant to individual needs so that they can connect personal aspirations with shared goals and build a strong sense of belonging. Being recognised as a Best Workplace confirms this commitment and serves as appreciation for the culture we have built together,” said Geraldine Koh, Regional HR & Communications Director, Asia Pacific.

Let us celebrate this achievement as evidence of the company’s commitment to placing employees as a priority and helping to shape the future of the healthcare and biopharmaceutical industry in Southeast Asia.

What is the “Southeast Asia Best Workplaces™ in Healthcare & Biopharma” list?

The “Southeast Asia Best Workplaces™ in Healthcare & Biopharma” list honours companies that have successfully built the best work cultures. This certification is based on confidential employee feedback and covers organisations in the healthcare, biopharmaceutical, and MedTech sectors, as well as other related industries that consistently provide a positive work experience for employees throughout Southeast Asia.

Why is this certification a regional-level recognition?

Unlike awards that only assess companies within a single country, this list evaluates and compares healthcare and biopharmaceutical companies from various Southeast Asian nations. The assessment is conducted comprehensively, taking into account diverse work cultures, workforce characteristics, and operational conditions in each country.